Joe Gerrard

ATR Inhibitor AZD6738 (Ceralasertib) Exerts Antitumor Activity as a Monotherapy and in Combination with Chemotherapy and the PARP Inhibitor Olaparib

A. Lau, M. O’Connor, R. Odedra, 2022, Cancer research.